Amanote Research
Register
Sign In
68. Immune Responses to Factor VIII Following Overexpression by Liver-Directed AAV Gene Therapy Do Not Correlate With Hepatic Cellular Stress Markers
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)35872-5
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2012
Authors
Unknown
Publisher
Elsevier BV
Related search
244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Major Role of Local Immune Responses in Antibody Formation to Factor IX in AAV Gene Transfer
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Tumour Necrosis Factor Receptor Gene Therapy Affects Cellular Immune Responses in Collagen Induced Arthritis in Mice
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Systemic Neutrophilic Responses Do Not Correlate With LPS-induced Neutrophilic Airway Inflammation
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Vaccine-Specific Immune Responses Correlate With Clinical Benefit
Cancer Discovery
Oncology
Immune Tolerance Induced by Platelet-Targeted Factor VIII Gene Therapy in Hemophilia a Mice Is CD4 T Cell-Mediated
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Efficacy and Safety of Long-Term Prophylaxis in Severe Hemophilia a Dogs Following Liver Gene Therapy Using AAV Vectors
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology